Related Experiment Video
Updated: Mar 15, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a
Olga Karicheva1, José Manuel Rodriguez-Vargas1, Nadège Wadier1
1Poly(ADP-ribosyl)ation and Genome Integrity, Laboratoire d'Excellence Medalis, UMR7242, Centre National de la Recherche Scientifique/Université de Strasbourg, Institut de Recherche de l'Ecole de Biotechnologie de Strasbourg, 67412 Illkirch, France.
Abstract:
Several members of the Poly(ADP-ribose) polymerase (PARP) family are essential regulators of genome integrity, actively prospected as drug targets for cancer therapy. Among them, PARP3 is well characterized for its functions in double-strand break repair and mitotis. Here we report that PARP3 also plays an integral role in TGFβ and reactive oxygen species (ROS) dependent epithelial-to-mesenchymal transition (EMT) and stem-like cell properties in human mammary epithelial and breast cancer cells. PARP3 expression is higher in breast cancer cells of the mesenchymal phenotype and correlates with the expression of the mesenchymal marker Vimentin while being in inverse correlation with the epithelial marker E-cadherin. Furthermore, PARP3 expression is significantly upregulated during TGFβ-induced EMT in various human epithelial cells. In line with this observation, PARP3 depletion alters TGFβ-dependent EMT of mammary epithelial cells by preventing the induction of the Snail-E-cadherin axis, the dissolution of cell junctions, the acquisition of cell motility and chemoresistance. PARP3 responds to TGFβ-induced ROS to promote a TG2-Snail-E-cadherin axis during EMT. Considering the link between EMT and cancer stem cells, we show that PARP3 promotes stem-like cell properties in mammary epithelial and breast cancer cells by inducing the expression of the stem cell markers SOX2 and OCT4, by increasing the proportion of tumor initiating CD44high/CD24low population and the formation of tumor spheroid bodies, and by promoting stem cell self-renewal. These findings point to a novel role of PARP3 in the control of TGFβ-induced EMT and acquisition of stem-like cell features and further motivate efforts to identify PARP3 specific inhibitors.
Insights
Poly(ADP-ribose) polymerase 3 (PARP3) is crucial for epithelial-to-mesenchymal transition (EMT) and stem-like properties in breast cancer cells. PARP3 promotes EMT by regulating key molecular axes and enhances cancer stem cell characteristics.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Poly(ADP-ribose) polymerase (PARP) family members are key in genome integrity and cancer drug development.
- PARP3 is known for its roles in DNA repair and mitosis.
- The function of PARP3 in epithelial-to-mesenchymal transition (EMT) and stemness remains largely unexplored.
Purpose of the Study:
- To investigate the role of PARP3 in TGFβ and reactive oxygen species (ROS)-induced EMT.
- To determine PARP3's involvement in the development of stem-like cell properties in breast cancer.
- To explore the therapeutic potential of targeting PARP3 in cancer.
Main Methods:
- Analysis of PARP3 expression in breast cancer cell lines with different phenotypes.
- Induction of EMT using TGFβ and assessment of PARP3 expression.
- Depletion of PARP3 using siRNA and evaluation of EMT markers and processes.
- Assessment of stem-like cell properties, including marker expression and spheroid formation.
Main Results:
- PARP3 expression is elevated in mesenchymal breast cancer cells and inversely correlates with E-cadherin, positively with Vimentin.
- PARP3 is upregulated during TGFβ-induced EMT and is essential for TGFβ-dependent EMT progression.
- PARP3 depletion inhibits EMT by affecting the Snail-E-cadherin axis, cell junctions, motility, and chemoresistance.
- PARP3 promotes stem-like properties by upregulating SOX2 and OCT4, increasing CD44high/CD24low population, and enhancing spheroid formation.
Conclusions:
- PARP3 plays a significant role in regulating TGFβ-induced EMT and stem-like cell characteristics in mammary epithelial and breast cancer cells.
- PARP3 acts through a TG2-Snail-E-cadherin axis, modulated by ROS, during EMT.
- These findings highlight PARP3 as a novel therapeutic target for inhibiting EMT and cancer stemness.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Negative Regulator Molecules
The Ras Gene
Ras is a...
Abnormal Proliferation

